So our district receivedtheir H2 budgets and each rep got between 3-5k combined for both products. Is this the same for all of you? It will last me 2 months!!!!
you have been previously warned, diabetes is being sold 4 Q, why would they give you a large budget. Bye bye baby
Do you really think that any office wants to hear about lantus or toujeo? You should enjoy the face that you can go hit the gym or come home for lunch a few days per week now!
Diabetes even while losing money brings in the most revenue. This rumor is far from fact. Cuts are coming but the division is not being sold. I think most of you know this. Sorry but this is the truth.
That's amazing Sanofi gave you your H2 budgets now. Genzyme loves to them out the following quarter. That way you know immediately you didn't come close to your goal, and the company already planned what little bonus to give you.
That is the truth until it isn't, but I agree that this will probably be the truth for a while. Diabetes brings in the most revenue, but it also accounts for a large percentage of the cost base. If Sanofi could get a good price for a declining business then they would, but it would necessitate seriously cutting back on corporate overhead and infrastructure. The annual trimming of the sales force in diabetes is but a mere shadow of what a serious corporate downsizing would involve. More importantly, once the infrastructure is gone then it limits what Sanofi can do next. If the plan were to consolidate around the Genzyme products, and there was a deep pipeline of recombinant protein drugs or mAbs coming to market in the next three years, that would be a very feasible strategy. However, absent a deep research pipeline, flogging the dead diabetes horse while avoiding further investment actually makes the most sense. Milking Lantus to the bitter end may be the least worst choice available.
